Coronary stenting in diabetic patients: Results from the ROSETTA registry

American Heart Journal

Volumn 142, Issue 6, 2001, Pages 960-964

  Huynh, Thao ^a,f   Eisenberg, Mark J ^b,f   Deligonul, Ubeydullah ^c,f   Tsang, Janius ^b,f   Okrainec, Karen ^b,f   Schechter, David ^d,f   Lefkovits, Jeffrey ^e,f   Mak, Koon Hou ^f,g   Brown, David L ^f,h   Brieger, David ^f,g  

^a MONTREAL GENERAL HOSPITAL   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c UNIVERSITY OF TEXAS HEALTH CENTER   (United States)

^d HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^e ROYAL MELBOURNE HOSPITAL   (Australia)

^f Department of Microbiology and Infectious Diseases   (Australia)

^g DEPARTMENT OF CARDIOLOGY   (Singapore)

^h ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; ATHERECTOMY; COMORBIDITY; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY OBSTRUCTION; CORONARY STENT; DIABETES MELLITUS; EXERCISE TEST; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RECURRENT DISEASE; REGRESSION ANALYSIS; TREATMENT OUTCOME;

EID: 0035210313     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1067/mhj.2001.119381     Document Type: Article

References (35)

1. Can restenosis after coronary angioplasty be predicted from clinical variables?
2. Restenosis after percutaneous yransluminal coronary angioplasty (PTCA): A report from the PTCA registry of the National Heart, Lung, and Blood Institute
3. Predictors of long-term cardiac survival in patients with multivessel coronary artery disease undergoing percutaneous transluminal coronary angioplasty
4. Risk stratification for long-term outcome after elective coronary angioplasty: A multivariate analysis of 5,000 patients
5. Influence of diabetes mellitus on early and late outcome after percutaneous transluminal coronary angioplasty
6. Coronary angioplasty in diabetic patients: The National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry
7. Quantitative analysis of elastic recoil after balloon angioplasty and after intracoronary implantation of balloon-expandable Palmaz-Schatz stents
8. Recoil following Wiktor stent implantation for restenotic lesions of coronary arteries
9. A randomized comparison of coronary stent placement and balloon angioplasty in patients with coronary artery disease: Benestent Study Group
10. A randomized comparison of coronary stent placement and balloon angioplasty in the treatment of coronary artery disease: Stent Restenosis Study Investigators
11. Restenosis rates in diabetic patients: A comparison of coronary stenting and balloon angioplasty in native coronary vessels
12. Predictors of restenosis after coronary stent implantation
13. Predictive factors of restenosis after coronary stent placement
14. Three-year clinical follow-up after Palmaz-Schatz stenting
15. The influence of diabetes mellitus on acute and late clinical outcomes following coronary stent implantation
16. Diabetes mellitus and the clinical and angiographic outcome after coronary stent placement
17. Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty
18. Clinical experience with the Palmaz-Schatz coronary stent: Initial results of a multicenter study
19. Increased restenosis in diabetes mellitus after coronary intervention is due to exaggerated intimal hyperplasia: A serial intravascular study
20. Insulin regulation of IGF-I expression in rat aorta
21. Insulin, insulin-like growth factor I and platelet-derived growth factor interact additively in the induction of protooncogene c-myc and cellular proliferation in cultured bovine aortic smooth muscle cells
22. Glucose and glucosamine regulate growth factors gene expression in vascular smooth muscle cells
23. Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilation in experimental diabetes
24. Advanced glycosylation end-products block the antiproliferative effects of nitric oxide
25. Free radicals mediate endothelial cell dysfunction caused by elevated glucose
26. Endothelial dysfunction in mesenteric resistance arteries of diabetic rats: Role of free radicals
27. Stimulation of endothelin-1 gene expression by insulin in endothelial cells
28. Insulin stimulates endothelin-1 secretion from human endothelial cells and modulates its circulating levels in vivo
29. Continued platelet interaction with de-endothelialized aorta associated with slower re-endothelialization and more extensive intimal hyperplasia in spontaneously diabetic BB Wistar rats
30. Platelet abnormalities in diabetes mellitus
31. Optimizing the percutaneous interventional outcomes for patients with diabetes mellitus: Results of the EPISTENT (Evaluation of Platelet IIB/IIIa Inhibitor for Stenting trial) diabetic substudy
32. Abciximab reduces mortality in diabetics following percutaneous coronary intervention
33. Diabetes mellitus: Biological determinants of atherosclerosis and restenosis
34. Potential mechanisms promoting restenosis in diabetic patients
35. Unstable angina: A comparison of angioscopic findings between diabetic and nondiabetic patients